Maharashtra on Saturday reported 1,723 COVID-19 cases and six deaths, which took the tally to 80,94,845 and the toll to 1,48,224, a health official said. This was a drop from the 1,846 cases recorded a day earlier, though the fatalities were higher, he pointed out.
Of the new cases, Mumbai Circle accounted for 1,144 cases, followed by 264 in Pune Circle, 154 in Nashik Circle, 58 in Kolhapur Circle, 43 in Nagpur Circle, 39 in Latur Circle, 12 in Aurangabad Circle, and nine in Akola Circle. Five deaths took place in Mumbai Circle and one in Nagpur, he added.
The recovery count increased by 1,845 in the last 24 hours to touch 79,34,878, leaving the state with an active caseload of 11,743, he said. Mumbai accounted for 5,177 of the active cases, followed by 2,449 in Thane and 1,803 in Pune districts, the official added.
State health department data revealed the recovery rate was 98.02 percent and the fatality rate stood at 1.83 percent. The positivity rate was 4.48 percent, while the overall number of coronavirus tests conducted so far was 8,40,21,397, including 38,421 in the last 24 hours.
Coronavirus figures of Maharashtra are as follows: Positive cases 8094845; fresh cases 1723; death toll 148224; recoveries 79,34,878; active cases 11743; total tests 8,40,21,397.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.